Clinical Trials Directory

Trials / Completed

CompletedNCT01383174

Nuevo Amanecer: Promoting the Psychosocial Health of Latinas

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
151 (actual)
Sponsor
University of California, San Francisco · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to test whether a new program Nuevo Amanecer (A New Dawn), improves the quality of life of Latinas diagnosed with breast cancer. Trained Latina counselors who have had breast cancer provide support to recently diagnosed women. The investigators call these counselors peer support counselors.

Detailed description

This study will assess the effectiveness of a cognitive-behavioral stress management (CBSM) intervention for newly diagnosed Latina breast cancer patients. In our prior work, the investigators established the appropriate content of the intervention, the need for early intervention, and the value of culturally competent peer support. In this study the investigators will adapt an evidence-based CBSM intervention designed to meet these needs. This study will use a randomized controlled trial (RCT) design with a wait-listed usual care control group to adapt the intervention and test its effectiveness in improving breast cancer specific quality-of-life, and decreasing anxiety and breast cancer specific distress. The new, adapted intervention will be called "Nuevo Amanecer" (A New Dawn).

Conditions

Interventions

TypeNameDescription
BEHAVIORALPeer Support Program* Work with a trained counselor who is a breast cancer survivor * Meet 8 times in-person over the 8 week program with the counselor * Counselor helps participant develop a personalized support program to help her improve her quality of life * Receives information on breast cancer, its treatments, and stress management

Timeline

Start date
2011-02-01
Primary completion
2014-05-01
Completion
2014-05-01
First posted
2011-06-28
Last updated
2019-01-15
Results posted
2015-06-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01383174. Inclusion in this directory is not an endorsement.